Clinical Trials Browser

Epidermolysis Bullosa Dystrophica × Clear all

NCT03786237 2026-02-24

Rigosertib for RDEB-SCC

Phase 1/2 Completed

Carcinoma, Squamous Cell, Epidermolysis Bullosa Dystrophica

NCT06423573 2025-09-19

FOSteR

Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Junctional